Abstract
Percutaneous alcohol septal ablation (PTSMA) has been established as therapy in symptomatic patients with hypertrophic obstructive cardiomyopathy [(1)][1]. Collateralization between the target septal branch and the left anterior descending coronary artery as well as another septal branch with
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have